The purpose of this study was to evaluate possible effects of quercetin (Q) on liver lipid metabolism and antioxidative status in periparturient dairy cows. The periparturient period is associated with enormous metabolic changes for dairy cows. Energy needs for incipient lactation are too high to be balanced by feed intake, leading to negative energy balance and body fat mobilization. It has been estimated that this leads to the development of fatty liver in about 50% of cows, which are at high risk for disease. Furthermore, the antioxidative status of these cows may be impaired. Quercetin is a plant flavonoid having hepatoprotective and antioxidative potential and the ability to reduce liver lipid accumulation in monogastric animals. Little information is available in regard to these effects in ruminants. To prevent microbial Q degradation in the rumen, Q was administered via a duodenal fistula to improve systemic availability. Five cows of the Q-treated group received, daily, 100 mg of quercetin dehydrate/kg BW in a 0.9% sodium chloride solution from d −20 until d 20 relative to calving, whereas 5 control (CTR) cows received only a sodium chloride solution. Blood samples were taken weekly and liver biopsies were performed in wk −4, −2, and 3 relative to calving. Cows treated with Q showed a tendency (P = 0.082) for lower liver fat content compared with CTR cows. Liver glycogen, glutathione concentrations, and relative mRNA abundance of genes related to hepatic lipid metabolism and antioxidative status as well as parameters of antioxidative status in plasma were not affected (P > 0.1) by Q supplementation. In conclusion, liver fat content in dairy cows tended to be reduced by Q supplementation, but potential underlying mechanisms remain unclear because analyzed parameters related to hepatic lipid metabolism and antioxidative defense were not altered by Q supplementation.
ABStRACt:
The purpose of this study was to evaluate possible effects of quercetin (Q) on liver lipid metabolism and antioxidative status in periparturient dairy cows. The periparturient period is associated with enormous metabolic changes for dairy cows. Energy needs for incipient lactation are too high to be balanced by feed intake, leading to negative energy balance and body fat mobilization. It has been estimated that this leads to the development of fatty liver in about 50% of cows, which are at high risk for disease. Furthermore, the antioxidative status of these cows may be impaired. Quercetin is a plant flavonoid having hepatoprotective and antioxidative potential and the ability to reduce liver lipid accumulation in monogastric animals. Little information is available in regard to these effects in ruminants. To prevent microbial Q degradation in the rumen, Q was administered via a duodenal fistula to improve systemic availability. Five cows of the Q-treated group received, daily, 100 mg of quercetin dehydrate/kg BW in a 0.9% sodium chloride solution from d −20 until d 20 relative to calving, whereas 5 control (CTR) cows received only a sodium chloride solution. Blood samples were taken weekly and liver biopsies were performed in wk −4, −2, and 3 relative to calving. Cows treated with Q showed a tendency (P = 0.082) for lower liver fat content compared with CTR cows. Liver glycogen, glutathione concentrations, and relative mRNA abundance of genes related to hepatic lipid metabolism and antioxidative status as well as parameters of antioxidative status in plasma were not affected (P > 0.1) by Q supplementation. In conclusion, liver fat content in dairy cows tended to be reduced by Q supplementation, but potential underlying mechanisms remain unclear because analyzed parameters related to hepatic lipid metabolism and antioxidative defense were not altered by Q supplementation.
INtRODUCtION
In early lactation, energy needs for milk secretion are higher than can be balanced by feed intake, which can lead to negative energy balance, body fat mobilization, and fatty liver (Bell, 1995; Coffey et al., 2002; Gross et al., 2013) . Fatty liver is estimated to occur in about 50% of cows and is often associated with hepatocellular damage and impaired hepatocyte function (Bobe et al., 2004; Esposito et al., 2014) . Additionally, both high milk output and high energy intake increase oxidative metabolism and production of reactive oxygen species (Sordillo et al., 2007; Celi, 2011) , which may further contribute to health problems (Spears and Weiss, 2008) . Fatty hepatocytes are especially vulnerable to oxidative damage (Yang et al., 2000) . Therefore, an antioxidant supplement may provide alleviation of peripartum diseases (Lykkesfeldt and Svendsen, 2007) . Flavonoids are phenolic substances found in higher plants (Nijveldt et al., 2001) . Quercetin (Q) is one of the major flavonoids and has been shown, mainly in rodents, to reduce liver lipid accumulation and incidence of fatty liver (Aguirre et al., 2011; Joven et al., 2012) . In addition, Q has antioxidant (Cui et al., 2014) and anti-inflammatory (Rathee et al., 2009) properties. Recently, we have reported that Q can decrease markers of liver damage in peripartal dairy cows (Stoldt et al., 2015) . Still, knowledge on flavonoid effects in ruminants is scarce, so we tested the hypothesis that Q has beneficial effects on liver lipid metabolism and antioxidative response in periparturient dairy cows. Our objectives were to investigate effects of Q on liver lipid content, plasma antioxidative status, and hepatic mRNA abundance of genes related to lipid metabolism and oxidative defense. To analyze principal effects of Q on dairy cow liver metabolism, Q was administered intraduodenally (Gohlke et al., 2013a) .
MAtERIALS AND MEtHODS

Animals and Diet
The procedures performed in this study were in accordance to the guidelines of the German animal protection regulations and were approved by the relevant authorities (Landesamt für Landwirtschaft, Lebensmittelsicherheit und Fischereiwesen, Mecklenburg-Vorpommern, Germany; LALLF M-V/TSD/7221.3-2.1-019/12).
Ten duodenally fistulated (Gohlke et al., 2013a ) German Holstein cows were monitored over a period of 7 wk, starting 4 wk before the estimated date of their third calving. Housing, feeding, milking procedures, and disease-related treatments and measurements of BW, DMI, and milk performance data were previously reported (Stoldt et al., 2015) . Because the fistula implantation itself and the housing of fistulated animals are considered wearing, we decided to keep the number of animals as small as possible. The Q-treated cows (n = 5) were dosed daily with 100 mg quercetin dihydrate (Carl Roth GmbH, Karlsruhe, Baden-Württemberg, Germany)/kg BW via the duodenal fistula starting 3 wk before and continuing until 3 wk after the estimated calving (d −20 ± 2.6 to +20 ± 1.5 relative to the true calving date). The dose was calculated based on the results of our previous study (Gohlke et al., 2013a) to generate an elevated plasma flavonoid level throughout the day. The amount was partitioned into 3 equal portions and suspended in 0.9% NaCl (Serumwerk Bernburg AG, Bernburg, Saxony-Anhalt, Germany), and the 3 portions were administered at 0630, 1200, and 1800 h to 5 cows. Another 5 cows received only a corresponding volume of NaCl solution and served as the control (CtR).
Blood Sampling and Analysis
Blood samples for isolation of plasma and leukocytes were drawn from the left jugular vein by venipuncture using the vacutainer system (Becton, Dickinson and Company, Plymouth, Devon, UK). Every experimental week, on Mondays at 0800 h, blood samples for leukocyte glutathione (GSH) measurement were taken (d −26 ± 0.9, −19 ± 0.7, −12 ± 0.8, −5 ± 0.8, 3 ± 0.8, 8 ± 1.1, and 17 ± 0.7 relative to the true calving date). Blood samples for ferric ion reducing antioxidant power (Frap), Trolox equivalent antioxidative capacity (tEAC), thiobarbituric acid reactive substances (tBARS), and F2-isoprostanes were withdrawn on Wednesdays at 1200 h (d −26 ± 0.4, −18 ± 0.5, −11 ± 0.6, −4 ± 0.6, 4 ± 0.4, 11 ± 0.6, and 18 ± 0.6 relative to the true calving date). One week before the start of the Q supplementation (d −23 ± 2.5), 1 wk before estimated calving (d −2 ± 0.3), and every week during the postpartum (pp) period (d 8 ± 0.3, 14 ± 0.6, and 21 ± 0.5 relative to the true calving date), blood samples for haptoglobin (Hp) measurement also were taken on Wednesday at 1200 h. Lithium heparin vacutainers (10 mL, 17 IU heparin/mL blood) were used to prepare plasma for the analysis of anti-/oxidative parameters and GSH, and potassium EDTA vacutainers (10 mL, 1.8 mg EDTA/mL blood) were used for analysis of Hp.
Blood samples (10 mL) for parameters of oxidative status and Hp concentrations were immediately centrifuged at 1,500 × g at 4°C for 20 min, and plasma aliquots were stored at −80°C. Leukocytes for GSH measurements were immediately isolated from blood samples (30 mL) by centrifugation at 1,200 × g at 4°C for 20 min using Biocoll (Biochrom GmbH, Berlin, Germany) as a separation medium and then thrice resuspended in PBS (PAA Lab GmbH, Pasching, Linz-Land, Austria), centrifuged at 300 × g at 4°C for 10 min, and stored at −80°C. Plasma NEFA and β-hydroxybutyrate (BHBA) were analyzed using an automatic analyzer and commercial kits as described by Stoldt et al. (2015) .
Plasma concentrations of Frap, TEAC, TBARS, and F2-isoprostanes were analyzed as described (Re et al., 1999; Luehring et al., 2011) . Intra-and interassay CV were 4.3 and 1.9% for Frap, 0.9 and 3.1% for TEAC, 11.1 and 2.5% for TBARS, and 35.7 and 33.5% for F2-isoprostanes, respectively.
To measure leukocyte GSH levels, the leukocyte pellet was resuspended in 150 μL ice-cold PBS, mixed, and centrifuged at 2,000 × g at 4°C for 5 min. Afterward, 150 μL cold 5% metaphosphoric acid was added to the supernatant, mixed, and centrifuged at 13,000 × g at 4°C for 10 min. Supernatants were transferred to HPLC vials and immediately injected or stored at −80°C until analysis. Analysis by HPLC was done according to Bayram et al. (2014) . Intra-and interassay CV were 3.7 and 5.3%, respectively.
Plasma Hp levels were analyzed using an ELISA as described by Hiss et al. (2004) . The serum used as a standard has been calibrated against a standard obtained from a European Union Concerted Action on the standardization of animal acute phase protein (QLK5- CT-1999-0153; Skinner, 2001) . Intra-and interassay CV were 3.9 and 12.2%, respectively. Plasma flavonoid concentrations were analyzed as previously described (Gohlke et al., 2013a) . Plasma total flavonoid concentrations were previously reported (Stoldt et al., 2015) . All analyses were performed in duplicate and merged as means.
Liver Sampling and Analysis
Before Q supplementation and in the first and last week of Q supplementation, corresponding to 4 and 2 wk antepartum (ap) and 3 wk after calving (d −26 ± 1.9, −12 ± 2.0, and 21 ± 0.7 relative to the true calving date), liver biopsies (1-2 g tissue on average) were aseptically taken at the 11th intercostal space after local anesthesia (procaine hydrochloride 20 mg/mL and epinephrine 0.025 mg/mL; Selectavet, Weyarn/ Holzolling, Bavaria, Germany) using a custom-made biopsy needle with a 6-mm o.d. Biopsied liver tissue samples were immediately frozen in liquid nitrogen and stored at −80°C.
Using a commercial photometric test kit (kit 10207748035; Boehringer Mannheim, Mannheim, Baden-Württemberg, Germany), liver glycogen content was determined in 25 mg of fresh liver tissue based on amyloglucosidase catalyzed glucose release. Carbon and nitrogen content of liver samples (at least 5 mg DM) were determined at the Institute of Chemistry, University of Rostock, Rostock, Germany. Based on this analysis, total liver fat content was calculated as described (Kuhla et al., 2004) Coefficients of determination (R 2 ) between predicted and measured fat values were 0.98, and the CV was 1.7%.
To measure GSH in liver tissue, preparation of liver samples was done according to Rebrin and Sohal (2004) . Liver samples (50 mg) were homogenized in 1 mL isolation buffer (0.25 M sucrose, 3 mM EDTA, and 10 mM Tris buffer, pH 7.4) at 25 Hz using TissueLyser II (Qiagen GmbH, Hilden, North-Rhine Westphalia, Germany) for 2.5 min. Immediately after homogenization, 200-μL aliquots were mixed with 200 μL of ice-cold 10% metaphosphoric acid. Samples were incubated on ice for 30 min. After centrifugation for 10 min at 14,000 × g at 4°C, the supernatant was transferred to HPLC vials and immediately injected or stored at −80°C until analysis. High-performance liquid chromatography analysis was done in duplicate according to Bayram et al. (2014) . Liver samples were pulverized in liquid nitrogen and homogenized using FastPrep 120 (Thermo Fisher Scientific, Karlsruhe, Baden-Württemberg, Germany) in TriFast (PeqLab Biotechnology, Erlangen, Bavaria, Germany). Total RNA was immediately extracted and stored at −80°C. Deoxyribonuclease digestion was done in solution (Qiagen GmbH) and RNA was purified using a spin column (RNeasy mini Kit; Qiagen GmbH). Purity and concentration of RNA were controlled using a NanoPhotometer (Implen GmbH, Hosseini et al. [2012] ); AHR = aryl hydrocarbon receptor; PON1 = paraoxonase; GPX1 = glutathione peroxidase (according to Gohlke et al. [2013b] ); SOD1 = superoxide dismutase (according to Gohlke et al. [2013b] ); CAT = catalase; DGAT1 = diglyceride acyltransferase; APOB = apolipoprotein B100; MTTP = microsomal triglyceride transfer protein (according to Loor et al. [2006] ).
Quantitative Real-Time PCR in Liver Samples
2 NIH = National Institutes of Health.
München, Bavaria, Germany) by absorbance reading at 260 and 280 nm. Corresponding RNA integrity numbers were assessed by microcapillary electrophoresis using the Bioanalyzer 2100 (Agilent Technologies Deutschland GmbH & Co. KG, Waldbronn, BadenWürttemberg, Germany) and RNA 6000 Nano Kit system (Agilent Technologies Deutschland GmbH & Co. KG). The mean RNA integrity factor was 6.1. Independent reverse transcription of 2 × 750 ng total RNA was performed with random hexamer primers (Metabion International AG, Planegg, Bavaria, Germany) and RevertAid reverse transcriptase (Thermo Fisher Scientific) with dNTP Mix (Thermo Fisher Scientific) in a total volume of 40 μL using a Thermocycler (Biometra GmbH, Göttingen, Lower Saxony, Germany) and afterward combined. Each run included a cDNA negative template control and no reverse transcriptase control. For inter-run calibrator preparation, samples were pooled before cDNA synthesis and transcribed. Inter-run calibrator was diluted 1:4 and 1:8 in water.
Before real-time PCR, cDNA was diluted 1:4 in water. Each real-time PCR run consisted of an interrun calibrator, negative template control for real-time PCR, cDNA negative template control, and no reverse transcriptase control of cDNA, and all samples as duplicates. A volume of 2 μL cDNA as a template and Luminaris Color HiGreen qPCR Master Mix (Thermo Fisher Scientific) in a total volume of 10 μL was run in a Light Cycler 2.0 (Roche Diagnostics Deutschland GmbH, Mannheim, Baden-Württemberg, Germany).
After each PCR cycle, a melting curve analysis was performed. The specificity of the PCR products was confirmed by sequencing. Amplification efficiencies were established using LinRegPCR version 2013.0 (Ruijter, Heart Failure Research Center, Amsterdam, North Holland, Netherlands; Ruijter et al., 2013) . Efficiencies of real-time PCR are shown in Table 1 .
Quantification cycle values were imported in qBase+ version 2.6.1 (Biogazelle, Ghent, Flanders, Belgium) and all subsequent calculations and data quality controls were done based on this software (Hellemans et al., 2007) . For normalization of the efficiency corrected data, emerin (EMD), hippocalcinlike 1 (HPCAL1), and low density lipoprotein receptor-related protein 10 (LRP10) were selected and used as reference genes (Saremi et al., 2012) . Data are presented as ratios of genes of interest and geometric mean of the selected reference genes' abundances.
Statistical Analysis
Data were analyzed with SAS/STAT 9.3 (SAS Inst. Inc., Cary, NC) using repeated-measurement ANOVA (PROC MIXED). Factors were Q (yes or no) and week relative to calving (wk −3, −2, and −1 before calving and wk 1, 2, and 3 after calving for blood parameters; wk −1 before calving and wk 1, 2, and 3 after calving for Hp; and wk −2 before calving and 3 after calving for liver parameters) as well as Q × week interaction. The covariance structure of the repeated factor week was modeled by autoregressive first-order (AR(1); smallest Akaike information criterion). Effects were considered significant at P ≤ 0.05 and least squares mean differences were tested using the Tukey-Kramer test. Significance levels of P ≤ 0.10 were considered a statistical trend. Data are presented as least squares means ± SE. Data were not tested for normal distribution because with an animal number of 10, testing and data transformation are not meaningful (Oztuna et al., 2006; Ghasemi and Zahediasl, 2012) .
RESULtS
Health Status
Plasma concentrations of NEFA and BHBA in cows were not affected by Q but by time (Stoldt et al., 2015) . As previously mentioned (Stoldt et al., 2015) , 1 of the control cows became clinically ketotic after calving; was appropriately treated with propylene glycol, Amynin (Merial GmbH, Halbergmoos, Bavaria, Germany), and Catosal (Bayer Vital GmbH, Leverkusen, North-Rhine Westphalia, Germany); and was provided with additional hay. Furthermore, 3 cows of each group were considered subclinically ketotic. These cows were not treated because of the absence of clinical signs (i.e., no decline of feed intake and milk yield). One cow of the Q-treated group and 2 of the CTR group had retained placentas and were treated with antibiotics in case of fever.
Plasma and Leukocyte Oxidative Status
Plasma oxidative and antioxidative parameters as well as leukocyte GSH were not affected by Q treatment. Plasma Frap increased (P = 0.034) from ap (89.9 ± 2.2 μmol/L in the Q group and 88.2 ± 2.4 μmol/L in the CTR group) to pp period (102.6 ± 6.4 μmol/L in the Q group and 109.3 ± 6.0 μmol/L in the CTR group), whereas TBARS decreased (P = 0.043; 0.4 ± 0.1 μmol/L to 0.3 ± 0.1 μmol/L in both groups). Plasma TEAC tended to decrease (P = 0.081) from ap (2.2 ± 0.1 mmol/L in both groups) to pp period (2.1 ± 0.1 mmol/L in the Q group and 2.2 ± 0.1 mmol/L in the CTR group).
Plasma Hp (Fig. 1) was affected by time (P = 0.006) and increased from before calving (355.8 ± 212.3 μg/ mL in the Q group and 311.6 ± 212.3 μg/mL in the CTR group) to the first week of the pp period (2,630.4 ± 522.3 μg/mL in the Q group and 1,734.8 ± 522.3 μg/ mL in the CTR group) and then decreased again until the third pp week (149.2 ± 677.3 μg/mL in the Q group and 623.8 ± 522.3 μg/mL in the CTR group).
Fat, Glycogen, and Glutathione in Liver
Liver fat content (Table 2) was affected by time. Treatment and the time × treatment interaction showed a statistical trend. Liver fat content (per DM) ranged during the pp period, from 9.5 to 43.8% in the Q group and from 38.8 to 62.1% in the CTR group. Liver glycogen content (Table 2) was not affected by Q but by time (P = 0.002). After calving, liver glycogen ranged from 0.5 to 1.4% in the Q group and from 0.4 to 3.7% in the CTR group. Liver GSH (Table 2) was affected neither by Q treatment nor by time.
Transcript Abundances in Liver
Abundances of all transcripts measured (Table 3) were not affected by Q treatment. Relative mRNA expression of MTTP increased (P = 0.004) from before (0.99 ± 0.08) to after calving (1.20 ± 0.19). Relative mRNA expression of SOD1 increased (P = 0.036) from the ap period (0.96 ± 0.07) to the pp period (1.17 ± 0.13).
DISCUSSION
Effects of Quercetin on Lipid Metabolism
The results of the present study show that there was a tendency toward a reduction of liver fat content in transition cows supplemented with Q. We have previously reported that plasma concentrations of Q and its metabolites were significantly increased in these cows whereas plasma NEFA, glucose, and BHBA concentrations as well as DMI and milk yield were not affected by Q (Stoldt et al., 2015) . As indicated by plasma BHBA values, some of our cows suffered from clinical or subclinical ketosis (McArt et al., 2012) . Because it is known that Q exerts its effects especially under adverse health conditions (Shao et al., 2013; Hashemzadeh-Cigari et al., 2014; Xu et al., 2014) , we deliberately choose the periparturient period to examine Q effects in cows.
In rodents, Q administration resulted in hepatic Q accumulation and regulated hepatic gene expression. In mice fed a high-fat diet (Jung et al., 2013) or with induced steatohepatitis (Marcolin et al., 2013) , Q suppletable 2. Liver fat, glycogen, and glutathione (GSH) status (least squares means ± SE) before (wk −4) and during (wk −2 and 3) quercetin supplementation from wk 3 before to wk 3 after parturition in cows (n = 5 per group) Values are least squares means ± SE of n = 5 cows per group. The shaded area indicates the period of quercetin supplementation from wk −3 to wk +3 relative to calving. The day of calving is represented by a dotted vertical line. The P-value for time was P < 0.006; for treatment and time × treatment interaction, P-values were P > 0.1. mentation reduced liver fat content. On d −26 before calving, all our cows had a low liver fat content, comparable with levels reported elsewhere (Djokovic et al., 2013; Weber et al., 2013) , but on d 21 after calving, Q-treated cows showed a moderately increased liver fat content whereas CTR cows reached higher values. This is in line with our finding that the liver enzymes glutamate dehydrogenase and aspartate aminotransferase, which are markers of liver damage, were higher after calving in CTR cows than in Q-treated cows (Stoldt et al., 2015) . Interestingly, Winkler et al. (2015) found a liver fat-reducing effect in transition cows supplemented with a plant product rich in polyphenols consisting of green tea and curcuma extract. In accordance with former studies, liver glycogen decreased after calving (Veenhuizen et al., 1991; Vazquez-Anon et al., 1994; Duske et al., 2009) , known to indicate an increased risk for metabolic disorders (Bobe et al., 2004) .
Hepatic mRNA abundances of selected genes involved in fatty acid metabolism were not influenced by Q administration. Others reported changes of hepatic mRNA abundance of related genes throughout the periparturient period (Graber et al., 2010; Loor et al., , 2006 , but in our cows, these transcripts were not influenced by time relative to calving. Indeed, the literature is inconsistent here and there are other studies (Loor et al., 2007; Van Dorland et al., 2012) that did not report changes in gene expression from the ap to pp table 3. Relative mRNA abundance (least squares means ± SE) of genes related to lipid metabolism and oxidative stress in the liver of cows (n = 5 per group) before the start of quercetin administration, and during quercetin supplementation in the antepartum and postpartum period (from 3 wk before to 3 wk after parturition) 2 Q = quercetin; CTR = control; ap = antepartum period (values of wk −2); pp = postpartum period (values of wk 3).
3 There were no significant interactions of treatment × time. period. It is also possible that differences between the ap and pp period depend on the sampling time relative to calving (Schäff et al., 2012) , and 21 d after calving was perhaps too late to detect changes in transcript expression. Only for MTTP, a protein assisting the assembly of apolipoprotein B-containing lipoproteins, could a higher relative expression be found after calving, but Schlegel et al. (2012) and Bernabucci et al. (2004) considered MTTP not relevant for etiology of fatty liver in ruminants. Plasma Hp, a major acute phase protein in ruminants (Eckersall, 2000) , is related to the development of fatty liver (Eckersall, 2000; Katoh, 2002) , and fatty infiltration is a stimulus for hepatocytes to produce Hp (Katoh, 2002) . Although cows of the Q-treated group experienced fatty liver to a somewhat lower extent, plasma Hp in our study did not differ among groups due to a relatively high variability but peaked at 1 wk after parturition, which is in line with previous reports (Ametaj et al., 2005; Bertoni et al., 2008; Hiss et al., 2009) . Others found that feeding transition cows a total mixed ration supplemented with a plant product from green tea and curcuma extract tended to reduce liver mRNA abundance of Hp in early lactation .
Effects of Quercetin on Oxidative Metabolism
Flavonoids act as antioxidants through their capacity to transfer electrons to free radicals and chelate metal catalyst and by activation of antioxidative enzymes (Middleton et al., 2000; Nijveldt et al., 2001; Heim et al., 2002) . Given that oxidative stress plays a central role in liver disease pathology and progression, antioxidants such as Q may be interesting as preventive agents (Crespo et al., 2008) . In addition, it has been shown that supplementation of a mixture of herbal plants can improve the antioxidative capacity in transition dairy cows (Hashemzadeh-Cigari et al., 2015) . To obtain a comprehensive picture of possible Q effects on antioxidative status, we investigated components of antioxidative defense at different levels. Although mRNA abundance of antioxidative enzymes was not influenced by Q treatment, we found increased mRNA concentration of SOD1 after calving in both groups, an enzyme that converts superoxides to less harmful compounds (Halliwell and Chirico, 1993) . Likewise, in a former study in midlactation cows, we found no effects of Q on mRNA abundance levels related to antioxidative effects (Gohlke et al., 2013b) . Plasma TBARS decreased from the ap to the pp period. This is surprising given that other studies found an increase of TBARS around or after calving (Bernabucci et al., 2005) and when fatty liver was present (Vendemiale et al., 2001 ).
However, TBARS are not specific to assess lipid peroxidation in vivo because the test also detects aldehydes other than malondialdehyde (Aoki et al., 2008; Celi, 2011) .
A possible reason for the lack of Q effects on hepatic mRNA abundance might be that the dose of Q applied or the duration of Q supplementation was insufficient to produce changes. It is also possible that the time of liver biopsy after parturition was too late to detect changes, because this might be a period where liver fat is already at its maximum or even already declining Graugnard et al., 2013) . The small number of animals used for the experiments might also be a factor explaining lack of effects. Nevertheless, given that Q tended to reduce liver fat, it is possible that there are underlying mechanisms other than those assessed in this study, such as enhanced hepatic ω-oxidation of lipids (Hoek-van den Hil et al., 2013) . A matter of recent discussion is also the reduction of endoplasmic reticulum stress by polyphenols Winkler et al., 2015) . In conclusion, in transition cows challenged by lipid mobilization, Q seems to attenuate liver fat deposition. This is in parallel with results of our previous study (Stoldt et al., 2015) were we found that Q lowered aspartate aminotransferase plasma values, which is a marker of liver health. However, because our study is limited in view of the small sample size due to the use of fistulated cows, further research is needed to clarify the mode of Q action in dairy cows in a larger number of cows with administration periods longer than 6 wk, including longer treatment periods both before and after calving. This, however, requires the development of rumen-protected Q preparations that can be orally applied.
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